1.A Case of Spurting Duodenal Variceal Bleeding Treated with an Endoscopic Sclerotherapy in a Patient with Biliary Cirrhosis.
Chan Sik WEON ; Soon Goo BAIK ; Sang Ha KIM ; Jung Koun KIM ; Houn Soo JOO ; Mi Young LEE ; Hyun Soo KIM ; Dong Ki LEE ; Sang Ok KOUN
Korean Journal of Gastrointestinal Endoscopy 2004;28(3):127-130
Duodenal varices can result from portal hypertension regardless of the etiologies of liver cirrhosis. Bleeding from duodenal varices is rare but often severe and life threatening. Treatment modalities of duodenal varices include endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and surgery. As an initial treatment, endoscopic sclerotherapy is recommended due to easy accessibility but has limited success in controlling active duodenal variceal bleeding. In this case, we report a spurting duodenal varix treated with Histoacryl(R) injection in a 48-year-old woman with secondary biliary cirrhosis. Endoscopic sclerotherapy with Histoacryl(R) is a useful therapeutic measure in the treatment of bleeding duodenal varix.
Esophageal and Gastric Varices*
;
Female
;
Hemorrhage
;
Humans
;
Hypertension, Portal
;
Liver Cirrhosis
;
Liver Cirrhosis, Biliary*
;
Middle Aged
;
Portasystemic Shunt, Surgical
;
Sclerotherapy*
;
Varicose Veins
2.High Resolution CT Findings of Pseudoalveolar Sarcoidosis.
Ji Eun NAM ; Young Hoon RYU ; Jun Gyun PARK ; Kyu Ok CHOE ; Jung Gi IM ; Kyoung Soo LEE ; Koun Sik SONG ; Hyae Young KIM ; Sang Jin KIM
Journal of the Korean Radiological Society 2002;47(2):191-196
PURPOSE: To determine the specific high-resolution CT features of sarcoidosis in which the observed pattern is predominantly pseudoalveolar. MATERIALS AND METHODS: We retrospectively reviewed the HRCT findings in 15 cases in which chest radiography demonstrated pseudoalveolar consolidation. In all 15, sarcoidosis was pathologically proven. The distribution and characterization of the following CT features was meticulously scrutinized: distribution and characterization of pseudoalveolar lesions, air-bronchograms, micronodules, thickening of bronchovascular bundles and interlobular septa, lung distortion, ground-glass opacities and combined hilar and mediastinal lymphadenopathy. Follow-up CT scans were available in three cases after corticosteroid administration. RESULTS: Between one and 12 (mean, 5.6) pseudoalveolar lesions appeared as dense homogeneous or inhomogeneous opacities 1-4.5 cm in diameter and with an irregular margin located either at the lung periphery adjacent to the pleural surface or along the bronchovascular bundles, with mainly bilateral distribution (n=14, 93%). An air-bronchogram was observed in ten cases. Micronodules were observed at the periphery of the lesion or surrounding lung, which along with a thickened bronchovascular bundle was a consistent feature in all cases. Additional CT features included hilar and mediastinal lymphadenopathy (n=14, 93%), thickened interlobular septa (n=12, 80%), and ground-glass opacity (n=10, 67%). Lung distortion was noted in only one case (7%). After steroid administration pseudoalveolar lesions decreased in number and size in all three cases in which follow-up CT was available. CONCLUSION: The consistent HRCT features of pseudoalveolar sarcoidosis are bilateral multifocal dense homogenous or inhomogenous opacity and an irregular margin located either at the lung periphery adjacent to the pleural surface or along the bronchovascular bundles. Micronodules are present at the periphery of the lesion or surrounding lung. The features are reversible at steroid administration.
Follow-Up Studies
;
Lung
;
Lymphatic Diseases
;
Radiography
;
Retrospective Studies
;
Sarcoidosis*
;
Thorax
;
Tomography, X-Ray Computed